2. 研究基础二
目前微生物感染尤其是真菌感染的发生率明显上升,成为威胁全球人类健康的严重问题。由于临床可用的抗真菌药物种类有限以及真菌耐药性越来越普遍,使得真菌的防治面临着严峻的挑战。我们实验室聚焦于皮肤或侵袭性真菌感染的免疫机制,并围绕着真菌与宿主之间的相互作用进行了系统性的研究工作,为将来通过交叉学科寻找新的药物靶点奠定了基础。
在真菌不同细胞器发现和鉴定了重要毒力因子,为抗真菌感染提供了潜在药物靶点。
相关文章:
1. Lu H*, Hong T*, Jiang Y, Whiteway M#, Zhang S#. Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies. Adv Drug Deliv Rev. 2023, Jun 10;114960.
2. Zhang S, Edwards TN, Mogavero S, Hube B, Berman J, Bougnoux ME, D'Enfert C, Kaplan DH. ATP released by Candida albicans is associated with reduced skin infectivity. J Invest Dermatol. 2021, 141(9):2306-2310.
3. Zhang SQ, Zou Z, Shen H, Shen SS, Miao Q, Huang X, Liu W, Li LP, Chen SM, Yan L, Zhang JD, Zhao JJ, Xu GT, An MM, Jiang YY. Mnn10 maintains pathogenicity in Candida albicans by extending α-1,6-mannose backbone to evade host Dectin-1 mediated antifungal immunity. PLoS Pathog. 2016, 12(5): e1005617.
4. Zhang SQ, Miao Q, Li LP, Zhang LL, Yan L, Jia Y, Cao YB, Jiang YY. Mutation of G234 Amino Acid Residue in Candida albicans Drug-resistance-related Protein Rta2p Is Associated with Fluconazole Resistance and Dihydrosphingosine Transport. Virulence, 2015, 6(6): 599-607.